Search

A patent has been issued for a system and method for digital imaging and communications in security (DICOS) standard compliance validation. The DICOS standard is a data communication and format-neutral standard used for security equipment, allowing for the interchange of information between different types of security equipment and manufacturers. The patent describes a system that tests whether a test subject is compliant with the DICOS standard by confirming the compliance of transmitted DICOS messages, logging any errors, and transmitting simulated DICOS messages. The system includes a processor, memory, and user interface, and can be implemented in various configurations. This patent provides a solution to the challenge of ensuring accurate configuration of security equipment and electronic files in compliance with the DICOS standard. [Extracted from the article]

A research article published in Blood Weekly provides an overview of the history of Ebola virus disease (EVD) outbreaks in Africa and examines the changes in medical and public health responses over time. The study analyzes available literature on major global Ebola outbreaks and identifies key factors such as transmission capacity, clinical symptoms, surveillance, virology, and outbreak control methods. The research concludes that while EVD has had significant health and societal impacts in Africa, there is hope for successful responses to future outbreaks through the use of endemic resources and international support. The article also highlights the availability of vaccines, antivirals, and public health measures to combat the disease. [Extracted from the article]

A patent has been issued for a neurosleeve device designed to assess pathological tremors. The device includes a wearable garment with electrodes that detect electromyography (EMG) signals and identify tremors based on anatomical location and time. The device applies neuromuscular electrical stimulation (NMES) to suppress the identified tremors. Current treatments for pathological tremors are not effective for a significant portion of the population, and existing methods for tremor suppression have limitations. The patent was filed by inventors from Battelle Memorial Institute and was published online in February 2024. [Extracted from the article]

Kimer Med, a biotech start-up based in New Zealand, has signed a contract with Battelle Memorial Institute to develop new antiviral drugs for the treatment of alphaviruses. The 12-month contract, funded by the United States government, aims to address the lack of effective antiviral treatments for alphavirus infections. Kimer Med has already developed antivirals that have shown efficacy against 11 different viruses, including Dengue and Zika. This contract is seen as an important milestone for Kimer Med in proving the capability of their platform for rapid antiviral development. [Extracted from the article]

A recent study conducted by researchers at the Battelle Memorial Institute in Columbus, Ohio, has shed light on Heartland virus disease (Heartland), an emerging infection transmitted through tick bites. The symptoms of Heartland virus disease include fever, fatigue, headaches, loss of appetite, and joint pain. The researchers recommend considering Heartland virus disease in patients with reported tick exposure, as the true range of the infection may be larger than currently understood. Early testing for Heartland virus disease is crucial, as patients who deteriorate to sepsis early in the course of the disease have a poor prognosis. [Extracted from the article]

A patent has been issued for a neurostimulation or electromyography cuff developed by inventors Chad E. Bouton and Jeffrey Friend and assigned to Battelle Memorial Institute. The system is designed to receive thought signals indicative of an intended action and provide electrical stimulation to damaged or degenerated neuromuscular regions to enable the intended action. The device can be used for therapeutic or rehabilitation purposes in patients with conditions such as spinal cord injury, stroke, nerve damage, or motor neural disease. The patent describes the use of flexible printed circuit boards with electrodes and a polyimide base layer to create a cuff that can be worn on the arm or leg. [Extracted from the article]

A recent study conducted by researchers at the Battelle Memorial Institute focused on developing a user-friendly, wearable electromyography (EMG)-based neural interface to decode hand and wrist movement intention in chronic stroke survivors with hemiparesis. The researchers developed the NeuroLife EMG System, which consists of a forearm sleeve with embedded electrodes and associated hardware and software to record and decode surface EMG. The study demonstrated accurate decoding of 12 functional hand, wrist, and forearm movements in stroke survivors, including those with severe hand impairment. The system also received positive feedback from stroke survivors, indicating that it meets various user needs. However, the NeuroLife EMG System is currently limited to investigational use due to U.S. federal law. [Extracted from the article]

A patent has been issued for autoinjectors with advanced release and sound features. The patent, assigned to Battelle Memorial Institute, addresses the challenges of delivering protein therapeutics through autoinjectors due to high viscosity and the need for sufficient force. The invention provides a method of releasing the injector mechanism by pressing an activation sleeve that rotates a locking collar, which in turn releases the autoinjector mechanism. The autoinjector also includes features such as a plunger screw, nut sectors, and an end cap to ensure proper functioning and feedback to the patient. [Extracted from the article]

Presents a speech by Douglas E. Olesen, President and Chief Executive Officer, Battelle, delivered to Conference on Medical Technology and Quality Health Care: A 21st Century Perspective, in Chicago, Illinois, on June 23, 1999 dealing with the issue of applications of emerging biomedical technologies.

Presents a speech by Battelle Senior Vice President William J. Madia delivered at The Planning Forum in Cambridge, Massachusetts on October 16, 1989. Developments in the economy of the European Community; Role of technology in the global market; Options for a company to increase its production and lower its costs.

Presents speech by the President and Chief Executive Officer of Batelle, delivered before The Institute for Science and Society on the occasion of Second Annual Gradil Auvil Lecture, dealing with forecasting of key technologies of the future. Public recognition of Battelle; Guidelines for future technological advancement; Role of education in economic development.

Presents speech by the Executive Communications Manager of Battelle, given at the Perry/Morgan County National Honor Society Recognition Conference, dealing with the issue of Battelle's vision of technology for the 21st Century. Explosion in health care technology; Biotechnology and the environment; Transportation; Commercial and industrial technology.

The article reports on the completion of the reorganization of Columbus, Ohio-based Battelle Memorial Institute under the supervision of president Bertram D. Thomas in 1965. It highlights the changes made on the research institute including the addition of 63% on its size, improved laboratory structure, and new management model. It notes that the modification is also triggered by the success of the institute to take over the operation of Atomic Research Commission (AEC) in Hanford, Washington.

The article highlights the ultrasonics technique developed by Frank Massa that degreased a metal part in about 10 seconds. Massa, head of Massa Laboratories of Cleveland, Ohio, invented the techniques as an efficient, low-cost production tool like induction heating. He made use of a device called magneto-striction transducer to produce the high-frequency, high-intensity sound waves, which was able to oscillate at 33,000 cycles per second. Battelle Memorial Institute of Ohio also used ultrasonics to measure the depth and angle of steel tubes.

The tremor suppression method of claim 1, wherein the using of the garment to measure modified tremors in the anatomical region is performed during the electrical stimulation by VNS or DBS. The tremor suppression method of claim 6, wherein the using of the garment to measure modified tremors in the anatomical region is performed during the electrical stimulation by VNS." The tremor suppression method of claim 6, wherein the anatomical region is at least one of an arm, a wrist and/or a hand, or a leg, an ankle, and/or a foot. [Extracted from the article]

Chlamydiaceae Infections, Chlamydophila Infections, Gram-Negative Bacteria, Health and Medicine, Psittacosis, Public Health Keywords for this news article include: Battelle Memorial Institute, Columbus, Ohio, United States, North and Central America, Psittacosis, Public Health, Health and Medicine, Gram-Negative Bacteria, Chlamydiaceae Infections, Chlamydophila Infections. Keywords: Chlamydiaceae Infections; Chlamydophila Infections; Gram-Negative Bacteria; Health and Medicine; Psittacosis; Public Health EN Chlamydiaceae Infections Chlamydophila Infections Gram-Negative Bacteria Health and Medicine Psittacosis Public Health 1612 1612 1 10/03/23 20231006 NES 231006 2023 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Fresh data on psittacosis are presented in a new report. [Extracted from the article]

"A garment comprising an array of electrodes embedded therein may be configured for NMES, EMG, or both NMES and EMG. The system of claim 15, wherein the electrode array is configured to perform functional electrical stimulation (FES), electromyography (EMG), or both FES and EMG. [Extracted from the article]

The presenting of the received semantic message is by operations including receiving a radio signal using a radio transceiver, determining the received semantic message from the received radio signal, and applying an electrical stimulation pattern to a body part wherein the electrical stimulation pattern represents the semantic message determined from the received radio signal. The information for encoding the electrical stimulation pattern representing the semantic message determined from the received radio signal comprises at least one look-up table that associates semantic messages with corresponding spatiotemporal electrical stimulation patterns. The medical diagnostic device of claim 7 wherein the patient wearable device and the physician wearable device are in communication via the Internet so as to apply the same spatiotemporal electrical stimulation pattern simulating the same type and/or level of pain at the same time using both the patient wearable device and the physician wearable device.". [Extracted from the article]

The method of claim 1, wherein the decoding algorithm receives EMG inputs from a user, generates a mapping between the received EMG inputs and joint angles, and predicts joint angles of a user based on the mapping. The EMG system of claim 18, wherein the first input is an input associated with EMG activity and the second input is an input associated with physical movements of at least one joint. The EMG system of claim 18, wherein the decoding algorithm receives EMG inputs from a user, generates a mapping between the received EMG inputs and joint angles, and predicts joint angles of a user based on the mapping.". [Extracted from the article]

The method of claim 9, wherein comparing the plurality of target text strings to the ambiguous text strings in the sequence-based computer file comprises comparing each target text string to each ambiguous text string that is associated with the same locus as that target text string. The method of claim 18, wherein comparing the plurality of target text strings to the ambiguous text strings in each of the plurality of computer files of the database comprises, for each computer file of the database, comparing each target text string to each ambiguous text string in that computer file that is associated with the same locus as that target text string.". [Extracted from the article]

The tremor suppression device of claim 1, wherein the electronic controller is configured to identify tremors further based on the orientation of the anatomical region. In some embodiments the garment further includes at least one inertial motion unit (IMU) and the electronic processor is configured to identify tremors further based on an orientation of the anatomical region determined using the IMU. The device of claim 10 further comprising: a garment wearable on the anatomical region and including the electrodes contacting the anatomical region when the garment is worn on the anatomical region. [Extracted from the article]

The apparatus of claim 1 wherein the electrical brain signal demultiplexing instructions are executable by the electronic processor to apply a machine learning component to demultiplex the at least one electrical brain signal into the efferent motor intention signal and the at least one afferent sensory signal. The non-transitory storage medium of claim 10 wherein the electrical brain signal demultiplexing instructions are executable by the electronic processor to demultiplex the at least one electrical brain signal into the efferent motor intention signal and the at least one afferent sensory signal further including at least an afferent proprioception sense signal generated by a proprioception sense of the paralyzed portion of the patient. The non-transitory storage medium of claim 10 wherein the electrical brain signal demultiplexing instructions are executable by the electronic processor to apply a machine learning component to demultiplex the at least one electrical brain signal into the efferent motor intention signal and the at least one afferent sensory signal. [Extracted from the article]

Keywords: Amides; Antibiotics; Antiinfectives; Beta-Lactam Antibiotics; Betaproteobacteria; Burkholderia; Burkholderia Infections; Burkholderia pseudomallei; Burkholderiaceae; Ceftazidime; Ceftazidime Therapy; Cephaloridine; Cephalosporins; Drugs and Therapies; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health and Medicine; Melioidosis; Organic Chemicals; Pharmaceuticals; Proteobacteria; Sulfur Compounds; Thiazines; Third Generation Cephalosporins EN Amides Antibiotics Antiinfectives Beta-Lactam Antibiotics Betaproteobacteria Burkholderia Burkholderia Infections Burkholderia pseudomallei Burkholderiaceae Ceftazidime Ceftazidime Therapy Cephaloridine Cephalosporins Drugs and Therapies Gram-Negative Aerobic Bacteria Gram-Negative Aerobic Rods and Cocci Gram-Negative Bacteria Gram-Negative Bacterial Infections Health and Medicine Melioidosis Organic Chemicals Pharmaceuticals Proteobacteria Sulfur Compounds Thiazines Third Generation Cephalosporins 1806 1806 1 04/03/23 20230407 NES 230407 2023 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Burkholderia pseudomallei is now available. Amides, Antibiotics, Antiinfectives, Beta-Lactam Antibiotics, Betaproteobacteria, Burkholderia, Burkholderia Infections, Burkholderia pseudomallei, Burkholderiaceae, Ceftazidime, Ceftazidime Therapy, Cephaloridine, Cephalosporins, Drugs and Therapies, Gram-Negative Aerobic Bacteria, Gram-Negative Aerobic Rods and Cocci, Gram-Negative Bacteria, Gram-Negative Bacterial Infections, Health and Medicine, Melioidosis, Organic Chemicals, Pharmaceuticals, Proteobacteria, Sulfur Compounds, Thiazines, Third Generation Cephalosporins. [Extracted from the article]

COVID-19, Coronavirus, Detergents, RNA Viruses, SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2, Surface-Active Agents, Viral, Virology Keywords: COVID-19; Coronavirus; Detergents; RNA Viruses; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Surface-Active Agents; Viral; Virology EN COVID-19 Coronavirus Detergents RNA Viruses SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Surface-Active Agents Viral Virology 648 648 1 03/27/23 20230327 NES 230327 2023 APR 2 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Weekly -- New research on COVID-19 is the subject of a new report. [Extracted from the article]

COVID-19, Coronavirus, RNA Viruses, SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2, Viral, Virology Keywords: COVID-19; Coronavirus; RNA Viruses; SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2; Viral; Virology EN COVID-19 Coronavirus RNA Viruses SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Viral Virology 577 577 1 03/27/23 20230327 NES 230327 2023 APR 2 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Weekly -- New research on COVID-19 is the subject of a new report. [Extracted from the article]

Significance and Impact ofStudy: SARS-CoV-2 virus on food coverings loses infectivity over acertain period, but PCR assays can still detect virus genomic materialthroughout the same time." For more information on this research see: Sars-cov-2 Persistence OnCommon Food Covering Materials: Plastic Wrap, Fruit Wax, and CardboardTakeout Containers. [Extracted from the article]

Because the electrodes are placed on the surface of the skin, rather than below it as in subcutaneous cuffs, stimulation often can better target skeletal muscle tissue or muscle groups, rather than peripheral nerves located deeper under the skin. Keywords: Algorithms; Battelle Memorial Institute EN Algorithms Battelle Memorial Institute 2677 2677 1 03/23/23 20230303 NES 230303 2023 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A patent by the inventors Bartholomew, John (Hilliard, OH, US), Friend, Jeffrey (Grove City, OH, US), filed on April 23, 2020, was published online on February 7, 2023, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. The neural signal processor also preferably includes an isolated pulse stimulator which receives a processed signal and generates a pulse signal for use in neuromuscular stimulation by an attached neuromuscular stimulation cuff 110.". [Extracted from the article]

The article offers brief information on equipment for U.S. Armed Forces Special Operations Forces (SOF) from companies including Family of Tactical Headborne Systems (FTHS) helmet from Revision Military, Non-Standard Commercial Vehicles (NSCVS) from Battelle, and camouflage systems from Saab. INSET: Portable Off-Grid Power for Special Forces.

In the gridlock of first-quarter 2015 earnings conference calls last spring, Doug Suttles, CEO at Alberta-based Encana Corp., talked bullishly about the Canadian energy company's production growth prospects. This while [...]

The article reports on the Northwestern Mutual Life Insurance Co. which along with Battelle Memorial Institute announced to invest 2.5 million dollars in the solar energy research by the institute. It also reports on the insurance company retaining the first right of refusal and retaining marketing rights on any commercially marketable products. The areas on which the funding focuses include solar powered irrigation pump, an inexpensive material for solar cells and photovoltaic cells.

The article discusses possible iron ore reserves available, since reserves are being diminished by 100,000,000 tons a year as of 1943. In Minnesota, 1,375,000,000 tons of high-grade ore reserves are estimated. It notes that several major mining companies have set up a 50,000 U.S. dollar-fund for research in utilizing low-grade hematite, to be undertaken by the Battelle Memorial Institute at Columbus, Ohio. In addition, several new mines have been opened, including additional open pits by Oliver Iron Mining Co.